Angiotensin II Infusion for Shock: A Multicenter Study of Postmarketing Use

BACKGROUND: Vasodilatory shock refractory to catecholamine vasopressors and arginine vasopressin is highly morbid and responsible for significant mortality. Synthetic angiotensin II is a potent vasoconstrictor that may be suitable for use in these patients. RESEARCH QUESTION: What is the safety and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Chest
Main Authors: Wieruszewski, Patrick M., Wittwer, Erica D., Kashani, Kianoush B., Brown, Daniel R., Butler, Simona O., Clark, Angela M., Cooper, Craig J., Davison, Danielle L., Gajic, Ognjen, Gunnerson, Kyle J., Tendler, Rachel, Mara, Kristin C., Barreto, Erin F.
Formato: Artigo
Idioma:Inglês
Publicado em: American College of Chest Physicians 2021
Assuntos:
Critical Care: Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7856533/
https://ncbi.nlm.nih.gov/pubmed/32882250
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chest.2020.08.2074
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados